Addition of alternate purchasing vehicles expected to help Mediware’s international business (JAC) continue to deliver double digit growth in UK
LENEXA KS, July 16, 2008 – Mediware Information Systems, Inc. (NASD: MEDW), a provider of ClosedLoop™ clinical systems for blood and medication management, announced that the Company’s UK-based JAC Computer Systems has been appointed to the ASCC (Additional Supply Capability and Capacity) framework contract in both the e-prescribing and pharmacy (stock control) categories. The ASCC contracts provide a framework for health care organizations to procure specialist services or complex multiple-system solutions at local, regional or even national levels.
“JAC has been a strong contributor for Mediware since the firm was acquired in 1996,” said Kelly Mann, Mediware’s president and chief executive officer. “We are the clear market leader in the UK for pharmacy stock control systems and our latest product for e-prescribing and medication administration has been successfully installed at 14 facilities, with several more in implementation.”
The strength of JAC’s product and service capabilities has continually delivered positive results to Mediware’s financial performance. Through the first three quarters of Fiscal Year 2008, Mediware has reported quarter to comparative quarter revenue growth for JAC of 29%, 19% and 37% respectively. Mediware will announce its full year results for FY 08 in early September.
JAC has a solid customer base and in 2005 was selected as a specialist provider of pharmacy stock control systems as part of the Connecting for Health’s national transformation program. JAC’s award is in cooperation with BT (British Telecom) for the London Region.
Delays in delivery from major National Program suppliers are expected to create additional opportunities for specialist suppliers like JAC. Appointment to the ASCC framework provides Hospital Trusts with a contracting vehicle to work directly with JAC and other qualified vendors to procure specialist e-prescribing and/or pharmacy stock control services as an alternative.
Commenting on the appointment, Robert Tysall-Blay, JAC’s Chief Executive said, “We feel it is a clear signal of our experience and expertise in medicines management that we have been listed in our own right as a specialist provider for both of these complex acute care settings.”
“We are further delighted that JAC’s services are also now available via the ASCC framework through a significant number of National and other Specialist SME partners’ solutions.”
JAC provides medication management solutions internationally for Mediware. It has more than 100 hospital customers in the United Kingdom, Ireland and South Africa.
Mediware delivers blood and medication management software systems that encapsulate information supporting patient therapies, reinforce patient safety practices and improve efficiencies to lower costs. Mediware’s customers include prestigious hospitals, clinics, correctional institutions, blood centers and other public and private health care institutions throughout the world. For more information about Mediware products and services, visit our web site at www.mediware.com.